These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 26573968)

  • 1. Plastin 3 is upregulated in iPSC-derived motoneurons from asymptomatic SMN1-deleted individuals.
    Heesen L; Peitz M; Torres-Benito L; Hölker I; Hupperich K; Dobrindt K; Jungverdorben J; Ritzenhofen S; Weykopf B; Eckert D; Hosseini-Barkooie SM; Storbeck M; Fusaki N; Lonigro R; Heller R; Kye MJ; Brüstle O; Wirth B
    Cell Mol Life Sci; 2016 May; 73(10):2089-104. PubMed ID: 26573968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Power of Human Protective Modifiers: PLS3 and CORO1C Unravel Impaired Endocytosis in Spinal Muscular Atrophy and Rescue SMA Phenotype.
    Hosseinibarkooie S; Peters M; Torres-Benito L; Rastetter RH; Hupperich K; Hoffmann A; Mendoza-Ferreira N; Kaczmarek A; Janzen E; Milbradt J; Lamkemeyer T; Rigo F; Bennett CF; Guschlbauer C; Büschges A; Hammerschmidt M; Riessland M; Kye MJ; Clemen CS; Wirth B
    Am J Hum Genet; 2016 Sep; 99(3):647-665. PubMed ID: 27499521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocalcin Delta Suppression Protects against Spinal Muscular Atrophy in Humans and across Species by Restoring Impaired Endocytosis.
    Riessland M; Kaczmarek A; Schneider S; Swoboda KJ; Löhr H; Bradler C; Grysko V; Dimitriadi M; Hosseinibarkooie S; Torres-Benito L; Peters M; Upadhyay A; Biglari N; Kröber S; Hölker I; Garbes L; Gilissen C; Hoischen A; Nürnberg G; Nürnberg P; Walter M; Rigo F; Bennett CF; Kye MJ; Hart AC; Hammerschmidt M; Kloppenburg P; Wirth B
    Am J Hum Genet; 2017 Feb; 100(2):297-315. PubMed ID: 28132687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plastin 3 expression in discordant spinal muscular atrophy (SMA) siblings.
    Bernal S; Also-Rallo E; Martínez-Hernández R; Alías L; Rodríguez-Alvarez FJ; Millán JM; Hernández-Chico C; Baiget M; Tizzano EF
    Neuromuscul Disord; 2011 Jun; 21(6):413-9. PubMed ID: 21546251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plastin 3 Expression Does Not Modify Spinal Muscular Atrophy Severity in the ∆7 SMA Mouse.
    McGovern VL; Massoni-Laporte A; Wang X; Le TT; Le HT; Beattie CE; Rich MM; Burghes AH
    PLoS One; 2015; 10(7):e0132364. PubMed ID: 26134627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling the differential phenotypes of spinal muscular atrophy with high-yield generation of motor neurons from human induced pluripotent stem cells.
    Lin X; Li JJ; Qian WJ; Zhang QJ; Wang ZF; Lu YQ; Dong EL; He J; Wang N; Ma LX; Chen WJ
    Oncotarget; 2017 Jun; 8(26):42030-42042. PubMed ID: 28159932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decay in survival motor neuron and plastin 3 levels during differentiation of iPSC-derived human motor neurons.
    Boza-Morán MG; Martínez-Hernández R; Bernal S; Wanisch K; Also-Rallo E; Le Heron A; Alías L; Denis C; Girard M; Yee JK; Tizzano EF; Yáñez-Muñoz RJ
    Sci Rep; 2015 Jun; 5():11696. PubMed ID: 26114395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CHP1 reduction ameliorates spinal muscular atrophy pathology by restoring calcineurin activity and endocytosis.
    Janzen E; Mendoza-Ferreira N; Hosseinibarkooie S; Schneider S; Hupperich K; Tschanz T; Grysko V; Riessland M; Hammerschmidt M; Rigo F; Bennett CF; Kye MJ; Torres-Benito L; Wirth B
    Brain; 2018 Aug; 141(8):2343-2361. PubMed ID: 29961886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog.
    Ohuchi K; Funato M; Kato Z; Seki J; Kawase C; Tamai Y; Ono Y; Nagahara Y; Noda Y; Kameyama T; Ando S; Tsuruma K; Shimazawa M; Hara H; Kaneko H
    Stem Cells Transl Med; 2016 Feb; 5(2):152-63. PubMed ID: 26683872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy.
    Oprea GE; Kröber S; McWhorter ML; Rossoll W; Müller S; Krawczak M; Bassell GJ; Beattie CE; Wirth B
    Science; 2008 Apr; 320(5875):524-7. PubMed ID: 18440926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcript levels of plastin 3 and neuritin 1 modifier genes in spinal muscular atrophy siblings.
    Yener İH; Topaloglu H; Erdem-Özdamar S; Dayangac-Erden D
    Pediatr Int; 2017 Jan; 59(1):53-56. PubMed ID: 27279027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plastin 3 ameliorates spinal muscular atrophy via delayed axon pruning and improves neuromuscular junction functionality.
    Ackermann B; Kröber S; Torres-Benito L; Borgmann A; Peters M; Hosseini Barkooie SM; Tejero R; Jakubik M; Schreml J; Milbradt J; Wunderlich TF; Riessland M; Tabares L; Wirth B
    Hum Mol Genet; 2013 Apr; 22(7):1328-47. PubMed ID: 23263861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of potential effects of Plastin 3 overexpression and low-dose SMN-antisense oligonucleotides on putative biomarkers in spinal muscular atrophy mice.
    Strathmann EA; Peters M; Hosseinibarkooie S; Rigo FW; Bennett CF; Zaworski PG; Chen KS; Nothnagel M; Wirth B
    PLoS One; 2018; 13(9):e0203398. PubMed ID: 30188931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete sequencing of the SMN2 gene in SMA patients detects SMN gene deletion junctions and variants in SMN2 that modify the SMA phenotype.
    Ruhno C; McGovern VL; Avenarius MR; Snyder PJ; Prior TW; Nery FC; Muhtaseb A; Roggenbuck JS; Kissel JT; Sansone VA; Siranosian JJ; Johnstone AJ; Nwe PH; Zhang RZ; Swoboda KJ; Burghes AHM
    Hum Genet; 2019 Mar; 138(3):241-256. PubMed ID: 30788592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic regulation of plastin 3 expression by the macrosatellite DXZ4 and the transcriptional regulator CHD4.
    Strathmann EA; Hölker I; Tschernoster N; Hosseinibarkooie S; Come J; Martinat C; Altmüller J; Wirth B
    Am J Hum Genet; 2023 Mar; 110(3):442-459. PubMed ID: 36812914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seamless Genetic Conversion of SMN2 to SMN1 via CRISPR/Cpf1 and Single-Stranded Oligodeoxynucleotides in Spinal Muscular Atrophy Patient-Specific Induced Pluripotent Stem Cells.
    Zhou M; Hu Z; Qiu L; Zhou T; Feng M; Hu Q; Zeng B; Li Z; Sun Q; Wu Y; Liu X; Wu L; Liang D
    Hum Gene Ther; 2018 Nov; 29(11):1252-1263. PubMed ID: 29598153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium binding is essential for plastin 3 function in Smn-deficient motoneurons.
    Lyon AN; Pineda RH; Hao le T; Kudryashova E; Kudryashov DS; Beattie CE
    Hum Mol Genet; 2014 Apr; 23(8):1990-2004. PubMed ID: 24271012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ZPR1 prevents R-loop accumulation, upregulates SMN2 expression and rescues spinal muscular atrophy.
    Kannan A; Jiang X; He L; Ahmad S; Gangwani L
    Brain; 2020 Jan; 143(1):69-93. PubMed ID: 31828288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modifier genes: Moving from pathogenesis to therapy.
    McCabe ERB
    Mol Genet Metab; 2017 Sep; 122(1-2):1-3. PubMed ID: 28684086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic modifiers ameliorate endocytic and neuromuscular defects in a model of spinal muscular atrophy.
    Walsh MB; Janzen E; Wingrove E; Hosseinibarkooie S; Muela NR; Davidow L; Dimitriadi M; Norabuena EM; Rubin LL; Wirth B; Hart AC
    BMC Biol; 2020 Sep; 18(1):127. PubMed ID: 32938453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.